Bullish option flow detected in Aurinia Pharmaceuticals with 6,006 calls trading, 3x expected, and implied vol increasing over 4 points to 55.82%. Oct-24 5 calls and Sep-24 8 calls are the most active options, with total volume in those strikes near 5,300 contracts. The Put/Call Ratio is 0.00. Earnings are expected on October 31st.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AUPH:
- Aurinia Pharmaceuticals Begins AUR200 Autoimmune Therapy Trial
- Aurinia Pharmaceuticals doses first participant in AUR200 trial
- Aurinia Pharmaceuticals call volume above normal and directionally bullish
- Aurinia Pharmaceuticals Posts Strong Q2 Financial Growth
- Aurinia Pharmaceuticals Files SEC Report, Shares Trade on Nasdaq